Publication | Closed Access
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels
307
Citations
28
References
2019
Year
MedicineBioanalysisHematologyLow Ferroportin LevelsPathologyPharmacologyRedox BiologyOxidative Stress
| Year | Citations | |
|---|---|---|
Page 1
Page 1